Luo Lih-Fen Holding Co., Ltd.

Luo Lih-Fen Holding Co., Ltd.

TTWSE:6666
40.50
TWD
-0.65
(-1.58%)
3.18EPS
12.77P/E
2.07BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
5.76
11.97
116.84
31.75
30.51
17.83
19.35
18.26
20.49
23.77
23.49
25.1
Basic EPS, GAAP
- -
0.32
2.17
29.76
10.08
10.5
2.2
1.48
1.16
1.86
1.7
2.42
3.42
Free Cash Flow per Basic Share
- -
0.05
4.96
44.78
10.3
-1.36
-2.73
-2.54
2.15
1.87
6.52
9.96
2.04
Dividend per Share
- -
- -
0.54
7.18
3.39
6.36
7
2
1.5
1.1
1.3
2
- -
Book Value per Share
- -
0.2
2.45
25.21
35.82
39
34.55
33.76
33.67
33.87
35.42
35.9
38.34
Tangible Book Value per Share
- -
0.19
2.43
25.16
35.79
38.8
33.64
32.92
32.86
33.14
34.76
35.3
37.75
Basic Weighted Avg Shares
36
36
36
7
43
47
47
47
47
47
47
47
47
Sales/Revenue/Turnover
- -
210
435
869
1,358
1,446
845
917
866
971
1,127
1,113
1,184
Operating Margin (%)
- -
7.23
24.04
36.29
42.13
36.47
7.01
5.8
5.1
7.39
8.12
11.05
14.31
Depreciation Expense
- -
5
5
9
21
35
49
60
62
56
67
60
62
Net Income, GAAP
- -
12
79
221
431
498
104
70
55
88
81
115
161
Effective Tax Rate (%)
- -
27.59
28.53
24.7
26.09
12.58
7.43
25.1
41.1
24.95
35.86
31.79
25.39
Profit Margin (%)
- -
5.53
18.09
25.47
31.75
34.43
12.33
7.66
6.33
9.09
7.17
10.31
13.63
Working Capital
- -
-90
-29
739
1,470
1,345
1,074
939
964
679
572
459
370
LT Debt
- -
- -
- -
- -
- -
6
99
113
179
65
50
45
42
Total Equity
- -
2
89
915
1,697
1,848
1,643
1,605
1,607
1,634
1,715
1,731
1,845
Return on Invested Capital (%)
- -
391.39
127.47
44.33
31.15
25.37
3.02
2.27
1.44
3
3.31
4.66
7.1
Return on Capital (%)
- -
1,079.93
159.23
40.31
33.01
28
5.86
4.13
3.3
5.19
4.28
6.87
9.9
Return on Common Equity (%)
- -
327.24
163.62
44.06
33.01
28.08
5.98
4.34
3.43
5.51
4.92
6.79
9.63

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
8
6
5
LT Borrowings
45
43
42
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
47
47
47
Market Capitalization
2,109
1,888
2,071

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
981
887
1,019
Cash, Cash Equivalents & STI
800
720
841
Accounts Receivable, Net
12
12
8
Inventories
92
90
109
Total Current Liabilities
522
386
649
Payables & Accruals
- -
- -
- -
ST Debt
8
6
5
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
507.19%
1.07%
0.9%
Free Cash Flow
1,067.71%
19.49%
52.77%
Net Income, GAAP
82.99%
8.01%
42.11%
Sales/Revenue/Turnover
25.79%
5.98%
-1.2%
Total Cash Common Dividend
- -
-10.21%
53.85%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
239
351
298
239
1,127
2025
248
348
257
259
1,113
2026
228
440
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.3
0.97
0.67
-0.24
1.7
2025
0.58
1.38
0.67
-0.21
2.42
2026
0.32
2.63
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.3
2025
- -
- -
- -
- -
2
2026
- -
- -
- -
- -
- -

Company Description

CEO
Li Fen Lo
Full Time Employees
547
Sector
Consumer non-durables
Industry
Household/Personal care
Address
No. 21, Longxiang Road Zhangzhou FU China KY1-1104
IPO Date
Nov 19, 2018
Business
Luo Lih-Fen Holding Co., Ltd. Luo Lih-Fen Holding Co., Ltd. (6666.TW) is a Cayman Islands-incorporated holding company founded in 2016 and headquartered in Grand Cayman that, through its subsidiaries, primarily engages in the research, development, manufacture, and sale of skincare and beauty care products in Taiwan and Mainland China. The company offers a diverse portfolio of facial beauty care products including facial cleansers, toners, essences, face creams, masks, eye kits, facial kits, health preservation kits, and oral health preservation foods; beauty care instruments and medical devices; raw materials, semi-finished products, and packaging materials; under brands such as LUO LIH-FEN, GLINGLUO, SUNLILY, DRAISE, QIECOME, EASYBIO, MALLSKIN, and YIN-NI. It also provides beauty and skincare consulting services, medical cosmetology services, operates and manages healthcare and biocare beauty salons including the RUILIJIA chain across the Taiwan Strait, and conducts general investment and real estate leasing activities, with primary manufacturing through Juwenlee (Fujian) Cosmetics Co., Ltd. in Zhangzhou Taiwanese Investment Zone, Fujian Province, China. Recent developments include the establishment of subsidiaries such as Xiamen Binnange Property Management Co., Ltd. in 2023 for asset utilization; Juliying (FuJian) Bio-Technology Co., Ltd. in 2023 to expand daily cosmetics sales; Xiamen Jialifenni Beauty Co., Ltd. and Juliying (Xiamen) Health Technology Co., Ltd. in 2024 for chain systems and skincare sales growth; Xiamen Siming District Ruilifenni Medical Beauty Clinic Co., Ltd. in 2024 to broaden sales channels; capital reduction and subsequent increase for Lever Guide Biotech Co., Ltd. in 2024 to improve financial structure; and a capital increase for Juwenlee (Fujian) Cosmetics Co., Ltd. in November 2024 via capitalization to replenish working capital.